Based on the identification and understanding of the cyclin-dependent kinase 4 (CDK4) and CDK6, the activator such as cyclin D1, and their multiple cyclin inhibitors, the concept of an inhibitor for cell cycle kinases to block cell cycle progression and tumor growth seems obvious (81). This evidence concerns the gene CDK4 and neoplasm.